| 2 nov. 2026 Déposé le 4 nov. 2026 | Davies Benjamin R. Officer: CVP Pres. Defense Systems | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Common Stock | Acquis (A) | 641 | 0 | — | 792 | Directe (D) | Non | — | Ouvrir le dépôt 0001628280-26-070174 Lu dans le XML du dépôt Contester cette ligne |
| 2 nov. 2026 Déposé le 4 nov. 2026 | Davies Benjamin R. Officer: CVP Pres. Defense Systems | F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 Common Stock | Cédé (D) | 281 | 555,32 | 156 044,92 Calculé : actions × prix par action. Valeur exacte 156044.92. | 511 | Directe (D) | Non | — | Ouvrir le dépôt 0001628280-26-070174 Lu dans le XML du dépôt Contester cette ligne |
| 2 nov. 2026 Déposé le 4 nov. 2026 | Davies Benjamin R. Officer: CVP Pres. Defense Systems | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Titre dérivé: Restricted Stock Rights — sous-jacent Common Stock (641) | Cédé (D) | 641 | 0 | — | 5 803 | Directe (D) | Non | F2, F3, F4 - F2 Each Restricted Stock Right (RSR) represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock.
- F3 Shares issued upon vesting of RSRs granted under the 2011 Long-Term Incentive Stock Plan (2011 LTISP) on 11/1/23 that vested on 11/2/26.
- F4 Total amount includes (i) 1,008 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (ii) 638 RSRs granted under the 2011 LTISP on 7/31/24 that will vest on 8/2/27 ; (iii) 2,456 RSRs granted under the 2024 Long-Term Incentive Stock Plan (2024 LTISP) on 2/18/25 that will vest on 2/18/28; and (iv) 1,701 RSRs granted under the 2024 LTISP on 2/11/26 that will vest on 2/12/29.
| Ouvrir le dépôt 0001628280-26-070174 Lu dans le XML du dépôt Contester cette ligne |
| 2 nov. 2026 Déposé le 3 nov. 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 7 | 553,39 | 3 873,73 Calculé : actions × prix par action. Valeur exacte 3873.73. | 4 405 | Directe (D) | Oui | F1, F2 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
- F2 Represents the weighted average sale price of $553.39 rounded to the nearest hundredth. The highest price at which the shares were sold was $553.80 and the lowest price at which the shares were sold was $553.19. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne |
| 2 nov. 2026 Déposé le 3 nov. 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 20 | 554,48 | 11 089,6 Calculé : actions × prix par action. Valeur exacte 11089.60. | 4 385 | Directe (D) | Oui | F1, F3 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
- F3 Represents the weighted average sale price of $554.48 rounded to the nearest hundredth. The highest price at which the shares were sold was $554.99 and the lowest price at which the shares were sold was $554.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne |
| 2 nov. 2026 Déposé le 3 nov. 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 20 | 555,46 | 11 109,2 Calculé : actions × prix par action. Valeur exacte 11109.20. | 4 365 | Directe (D) | Oui | F1, F4 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
- F4 Represents the weighted average sale price of $555.46 rounded to the nearest hundredth. The highest price at which the shares were sold was $555.89 and the lowest price at which the shares were sold was $555.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne |
| 2 nov. 2026 Déposé le 3 nov. 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 50 | 556,47 | 27 823,5 Calculé : actions × prix par action. Valeur exacte 27823.50. | 4 315 | Directe (D) | Oui | F1, F5 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
- F5 Represents the weighted average sale price of $556.47 rounded to the nearest hundredth. The highest price at which the shares were sold was $556.60 and the lowest price at which the shares were sold was $556.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne |
| 2 nov. 2026 Déposé le 3 nov. 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 1 | 557,47 | 557,47 Calculé : actions × prix par action. Valeur exacte 557.47. | 4 314 | Directe (D) | Oui | F1 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 27, 2026.
| Ouvrir le dépôt 0001628280-26-069214 Lu dans le XML du dépôt Contester cette ligne |
| 30 sept. 2026 Déposé le 1 oct. 2026 | KRISHNA ARVIND Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 75 | 483,48 | 36 261 Calculé : actions × prix par action. Valeur exacte 36261.00. | 2 837 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-064144 Lu dans le XML du dépôt Contester cette ligne |
| 30 sept. 2026 Déposé le 1 oct. 2026 | Brown Marianne Catherine Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 96 | 483,48 | 46 414,08 Calculé : actions × prix par action. Valeur exacte 46414.08. | 11 706 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-064142 Lu dans le XML du dépôt Contester cette ligne |
| 19 août 2026 Déposé le 21 août 2026 | Warden Kathy J Director · Officer: Chair, CEO and President | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Titre dérivé: Market Stock Units — sous-jacent Common Stock (35 910) | Acquis (A) | 35 910 | 0 | — | 35 910 | Directe (D) | Non | F1 - F1 Each Market Stock Unit (MSU) represents the contingent right to receive, following vesting, between 0% and 150% of one share of the Issuer's common stock, subject to the Issuer's absolute stock price appreciation or depreciation over a performance period ending December 31, 2031. No portion of the MSUs will be earned if the Issuer's stock price depreciates by more than 25%, a 100% (or target) payout is earned if the Issuer's stock price appreciates by 10%, and a 150% payout is earned if the Issuer's stock price appreciates by 50% or more. The target number of MSUs is reported in this Report. Grant awarded pursuant to Rule 16b-3(d).
| Ouvrir le dépôt 0001628280-26-058482 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 8 | 544,53 | 4 356,24 Calculé : actions × prix par action. Valeur exacte 4356.24. | 4 480 | Directe (D) | Oui | F1, F2 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F2 Represents the weighted average sale price of $544.53 rounded to the nearest hundredth. The highest price at which the shares were sold was $544.81 and the lowest price at which the shares were sold was $544.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 19 | 545,59 | 10 366,21 Calculé : actions × prix par action. Valeur exacte 10366.21. | 4 461 | Directe (D) | Oui | F1, F3 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F3 Represents the weighted average sale price of $545.59 rounded to the nearest hundredth. The highest price at which the shares were sold was $545.82 and the lowest price at which the shares were sold was $545.12. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 11 | 546,42 | 6 010,62 Calculé : actions × prix par action. Valeur exacte 6010.62. | 4 450 | Directe (D) | Oui | F1, F4 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F4 Represents the weighted average sale price of $546.42 rounded to the nearest hundredth. The highest price at which the shares were sold was $546.89 and the lowest price at which the shares were sold was $546.05. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 31 | 547,42 | 16 970,02 Calculé : actions × prix par action. Valeur exacte 16970.02. | 4 419 | Directe (D) | Oui | F1, F5 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F5 Represents the weighted average sale price of $547.42 rounded to the nearest hundredth. The highest price at which the shares were sold was $547.94 and the lowest price at which the shares were sold was $547.12. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 10 | 548,32 | 5 483,2 Calculé : actions × prix par action. Valeur exacte 5483.20. | 4 409 | Directe (D) | Oui | F1, F6 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F6 Represents the weighted average sale price of $548.32 rounded to the nearest hundredth. The highest price at which the shares were sold was $548.78 and the lowest price at which the shares were sold was $548.11. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 6 | 549,50 | 3 297 Calculé : actions × prix par action. Valeur exacte 3297.00. | 4 403 | Directe (D) | Oui | F1, F7 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F7 Represents the weighted average sale price of $549.50 rounded to the nearest hundredth. The highest price at which the shares were sold was $549.74 and the lowest price at which the shares were sold was $549.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 2 | 550,68 | 1 101,36 Calculé : actions × prix par action. Valeur exacte 1101.36. | 4 401 | Directe (D) | Oui | F1 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 2 | 552,95 | 1 105,9 Calculé : actions × prix par action. Valeur exacte 1105.90. | 4 399 | Directe (D) | Oui | F1 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 2 | 553,90 | 1 107,8 Calculé : actions × prix par action. Valeur exacte 1107.80. | 4 397 | Directe (D) | Oui | F1 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 3 août 2026 Déposé le 4 août 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 4 | 554,14 | 2 216,56 Calculé : actions × prix par action. Valeur exacte 2216.56. | 4 393 | Directe (D) | Oui | F1, F8 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F8 Represents the weighted average sale price of $554.14 rounded to the nearest hundredth. The highest price at which the shares were sold was $554.17 and the lowest price at which the shares were sold was $554.11. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-052370 Lu dans le XML du dépôt Contester cette ligne |
| 30 juin 2026 Déposé le 1 juil. 2026 | KRISHNA ARVIND Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 71 | 509,31 | 36 161,01 Calculé : actions × prix par action. Valeur exacte 36161.01. | 2 749 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-046449 Lu dans le XML du dépôt Contester cette ligne |
| 30 juin 2026 Déposé le 1 juil. 2026 | Brown Marianne Catherine Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 91 | 509,31 | 46 347,21 Calculé : actions × prix par action. Valeur exacte 46347.21. | 11 558 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-046450 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | SCHOEWE THOMAS M Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 16 737 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Amount includes (i) 3,160 shares of common stock; and (ii) 13,577 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011
Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037205 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | Brown Marianne Catherine Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 11 415 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on
shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037195 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | Turley James S Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 6 738 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Amount includes (i) 635 shares of common stock; and (ii) 6,103 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011
Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037207 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | ABNEY DAVID P Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 2 824 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Amount includes (i) 2,475 shares of common stock; and (ii) 349 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the
stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037192 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | KRISHNA ARVIND Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 2 666 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on
shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037199 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | Ross Kimberly A. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 1 612 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on
shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037201 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | WINSTON MARY A Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 1 609 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Amount includes (i) 78 shares of common stock; and (ii) 1,540 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011
Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037211 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | Grady Christopher W. Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 421 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2024 Long-Term Incentive Stock Plan. Dividends earned on
shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037197 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | WELSH MARK A III Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 4 470 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Amount includes (i) 488 shares of common stock; and (ii) 3,982 shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011
Long-Term Incentive Stock Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under Rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037209 Lu dans le XML du dépôt Contester cette ligne |
| 20 mai 2026 Déposé le 21 mai 2026 | ROUGHEAD GARY Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 349 | 552,17 | 192 707,33 Calculé : actions × prix par action. Valeur exacte 192707.33. | 12 210 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan and the Northrop Grumman 2011 Long-Term Incentive Stock Plan. Dividends earned on
shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-037203 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 1 | 566,60 | 566,6 Calculé : actions × prix par action. Valeur exacte 566.60. | 4 215 | Directe (D) | Oui | F1 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 5 | 568,75 | 2 843,75 Calculé : actions × prix par action. Valeur exacte 2843.75. | 4 210 | Directe (D) | Oui | F1, F2 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F2 Represents the weighted average sale price of $568.75 rounded to the nearest hundredth. The highest price at which the shares were sold was $568.92 and the lowest price at which the shares were sold was $568.49. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 9 | 569,49 | 5 125,41 Calculé : actions × prix par action. Valeur exacte 5125.41. | 4 201 | Directe (D) | Oui | F1, F3 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F3 Represents the weighted average sale price of $569.49 rounded to the nearest hundredth. The highest price at which the shares were sold was $569.97 and the lowest price at which the shares were sold was $569.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 43 | 570,47 | 24 530,21 Calculé : actions × prix par action. Valeur exacte 24530.21. | 4 158 | Directe (D) | Oui | F1, F4 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F4 Represents the weighted average sale price of $570.47 rounded to the nearest hundredth. The highest price at which the shares were sold was $570.84 and the lowest price at which the shares were sold was $570.25. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 3 | 571,74 | 1 715,22 Calculé : actions × prix par action. Valeur exacte 1715.22. | 4 155 | Directe (D) | Oui | F1, F5 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F5 Represents the weighted average sale price of $571.74 rounded to the nearest hundredth. The highest price at which the shares were sold was $571.98 and the lowest price at which the shares were sold was $571.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 6 | 572,72 | 3 436,32 Calculé : actions × prix par action. Valeur exacte 3436.32. | 4 149 | Directe (D) | Oui | F1, F6 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F6 Represents the weighted average sale price of $572.72 rounded to the nearest hundredth. The highest price at which the shares were sold was $572.98 and the lowest price at which the shares were sold was $572.51. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 14 | 573,51 | 8 029,14 Calculé : actions × prix par action. Valeur exacte 8029.14. | 4 135 | Directe (D) | Oui | F1, F7 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F7 Represents the weighted average sale price of $573.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $573.80 and the lowest price at which the shares were sold was $573.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 2 | 574,51 | 1 149,02 Calculé : actions × prix par action. Valeur exacte 1149.02. | 4 133 | Directe (D) | Oui | F1, F8 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F8 Represents the weighted average sale price of $574.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $574.66 and the lowest price at which the shares were sold was $574.35. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 4 | 575,59 | 2 302,36 Calculé : actions × prix par action. Valeur exacte 2302.36. | 4 129 | Directe (D) | Oui | F1, F9 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F9 Represents the weighted average sale price of $575.59 rounded to the nearest hundredth. The highest price at which the shares were sold was $575.99 and the lowest price at which the shares were sold was $575.38. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 7 | 576,38 | 4 034,66 Calculé : actions × prix par action. Valeur exacte 4034.66. | 4 122 | Directe (D) | Oui | F1, F10 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
- F10 Represents the weighted average sale price of $576.38 rounded to the nearest hundredth. The highest price at which the shares were sold was $576.87 and the lowest price at which the shares were sold was $576.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 4 mai 2026 Déposé le 5 mai 2026 | WELSH MARK A III Director | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 1 | 577,05 | 577,05 Calculé : actions × prix par action. Valeur exacte 577.05. | 4 121 | Directe (D) | Oui | F1 - F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025.
| Ouvrir le dépôt 0001628280-26-030668 Lu dans le XML du dépôt Contester cette ligne |
| 31 mars 2026 Déposé le 2 avr. 2026 | KRISHNA ARVIND Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 53 | 682,24 | 36 158,72 Calculé : actions × prix par action. Valeur exacte 36158.72. | 2 317 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-022974 Lu dans le XML du dépôt Contester cette ligne |
| 31 mars 2026 Déposé le 2 avr. 2026 | Brown Marianne Catherine Director | A Grant, award or other acquisition pursuant to Rule 16b-3(d) Common Stock | Acquis (A) | 68 | 682,24 | 46 392,32 Calculé : actions × prix par action. Valeur exacte 46392.32. | 11 066 | Directe (D) | Non | F1, F2 - F1 Represents shares of common stock deferred into a stock unit account pursuant to the Northrop Grumman 2024 Long-Term Incentive Stock Plan (the Plan) in a transaction exempt pursuant to Rule 16b-3.
- F2 Represents shares of common stock, including dividends, held in a stock unit account pursuant to the Plan. Dividends earned on shares held in the stock unit account were exempt from Section 16 and not reportable under rule 16a-11.
| Ouvrir le dépôt 0001628280-26-022976 Lu dans le XML du dépôt Contester cette ligne |
| 2 mars 2026 Déposé le 3 mars 2026 | Simpson Kathryn G Officer: Corp VP General Counsel | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 873 | 745 | 650 385 Calculé : actions × prix par action. Valeur exacte 650385. | 1,39 | Directe (D) | Oui | F1 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2025.
| Ouvrir le dépôt 0001628280-26-013772 Lu dans le XML du dépôt Contester cette ligne |
| 27 févr. 2026 Déposé le 2 mars 2026 | ROEDER ROSHAN S Officer: CVP Pres. Mission Systems | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 1 754 | 720 | 1 262 880 Calculé : actions × prix par action. Valeur exacte 1262880. | 2 353,39 | Directe (D) | Oui | F1 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 30, 2025.
| Ouvrir le dépôt 0001628280-26-013201 Lu dans le XML du dépôt Contester cette ligne |
| 19 févr. 2026 Déposé le 20 févr. 2026 | Simpson Kathryn G Officer: Corp VP General Counsel | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 194 | 727,62 | 141 158,28 Calculé : actions × prix par action. Valeur exacte 141158.28. | 874,39 | Directe (D) | Oui | F1 - F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2025.
| Ouvrir le dépôt 0001628280-26-010367 Lu dans le XML du dépôt Contester cette ligne |
| 19 févr. 2026 Déposé le 20 févr. 2026 | Hardesty Michael A Officer: Corp VP, Controller CAO | S Open market or private sale of non-derivative or derivative security Common Stock | Cédé (D) | 147 | 732,98 | 107 748,06 Calculé : actions × prix par action. Valeur exacte 107748.06. | 2 525,29 | Directe (D) | Non | — | Ouvrir le dépôt 0001628280-26-010262 Lu dans le XML du dépôt Contester cette ligne |